Hepatitis B virus (HBV) infection and recombination between HBV genotypes D and E in asymptomatic blood donors from Khartoum, Sudan
- PMID: 21048009
- PMCID: PMC3020474
- DOI: 10.1128/JCM.00867-10
Hepatitis B virus (HBV) infection and recombination between HBV genotypes D and E in asymptomatic blood donors from Khartoum, Sudan
Abstract
Sudan is a highly endemic area for hepatitis B virus (HBV), and >5% of blood donors are chronically infected. To examine potential strategies to improve HBV blood safety, 404 replacement donor samples previously screened for HBV surface antigen (HBsAg) were tested for antibody to HBV core (anti-HBc), anti-surface antigen (anti-HBs), and HBV DNA. Of 145 anti-HBc-containing samples (36%) identified, 16 retested were HBsAg positive (11%). Anti-HBs was detected in 43/77 (56%) anti-HBc-reactive samples. Six samples were HBsAg(-)/anti-HBc(+)/anti-HBs(+) and contained HBV DNA, meeting the definition of occult HBV infection (OBI). OBIs had low HBV DNA loads (<10 IU/ml) and were genotype B (n = 1) or genotype D (n = 5). Pre-S/S and/or whole genome sequences were obtained from 47 randomly selected HBsAg-positive donors added to the previous 16. Genotype E was identified in 27 strains (57.5%), genotype D in 19 strains (40.5%), and genotype A2 in 1 strain (2%). Two outlier strains within genotype D ultimately were identified as recombinants of genotypes D and E with identical recombination points, suggesting circulating, infectious, recombinant strains. Anti-HBc screening does not appear to be a sustainable blood safety strategy because of the cost and the negative impact on the Sudanese blood supply, even when reduced by anti-HBs testing. Being at the junction between two main African HBV genotypes, genetic recombination occurred and became part of the molecular epidemiology of HBV in Sudan.
Figures




Similar articles
-
Molecular and serological characterization of hepatitis B virus genotype A and D infected blood donors in Poland.J Viral Hepat. 2010 Jun;17(6):444-52. doi: 10.1111/j.1365-2893.2009.01192.x. Epub 2009 Sep 25. J Viral Hepat. 2010. PMID: 19780948
-
Incidence of Occult Hepatitis B Infection (OBI) and hepatitis B genotype characterization among blood donors in Cameroon.PLoS One. 2024 Oct 16;19(10):e0312126. doi: 10.1371/journal.pone.0312126. eCollection 2024. PLoS One. 2024. PMID: 39413100 Free PMC article.
-
Blood donor screening in the Netherlands: Universal anti-HBc screening in combination with HBV nucleic acid amplification testing may allow discontinuation of hepatitis B virus antigen testing.Transfusion. 2021 Jul;61(7):2116-2124. doi: 10.1111/trf.16420. Epub 2021 Apr 26. Transfusion. 2021. PMID: 33899233
-
Low Prevalence of Anti-HBc Antibody and Lack of HBV DNA Among HBsAg-Negative Blood Donors in Iran: A Cross-sectional Study and Review of Literature.Arch Iran Med. 2024 Jun 1;27(6):305-312. doi: 10.34172/aim.28579. Epub 2024 Apr 27. Arch Iran Med. 2024. PMID: 38855800 Free PMC article. Review.
-
New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods.Mol Diagn Ther. 2006;10(2):77-91. doi: 10.1007/BF03256447. Mol Diagn Ther. 2006. PMID: 16669606 Review.
Cited by
-
Characterization of small genomic regions of the hepatitis B virus should be performed with more caution.Virol J. 2018 Dec 10;15(1):188. doi: 10.1186/s12985-018-1100-x. Virol J. 2018. PMID: 30526629 Free PMC article.
-
Disproportionate Distribution of HBV Genotypes A and D and the Recombinant Genotype D/E in the High and Low HBV Endemic Regions of Uganda: A Wake-Up Call for Regional Specific HBV Management.Int J Hepatol. 2022 Jan 11;2022:3688547. doi: 10.1155/2022/3688547. eCollection 2022. Int J Hepatol. 2022. PMID: 35070455 Free PMC article.
-
Insights into the genetic diversity, recombination, and systemic infections with evidence of intracellular maturation of hepadnavirus in cats.PLoS One. 2020 Oct 23;15(10):e0241212. doi: 10.1371/journal.pone.0241212. eCollection 2020. PLoS One. 2020. PMID: 33095800 Free PMC article.
-
Genetic diversity and occult hepatitis B infection in Africa: A comprehensive review.World J Hepatol. 2024 May 27;16(5):843-859. doi: 10.4254/wjh.v16.i5.843. World J Hepatol. 2024. PMID: 38818293 Free PMC article.
-
Molecular epidemiology of hepatitis B virus among HIV co-infected and mono-infected cohorts in Northwest Ethiopia.Virol J. 2022 Mar 24;19(1):53. doi: 10.1186/s12985-022-01774-6. Virol J. 2022. PMID: 35331278 Free PMC article.
References
-
- Allain, J.-P. 2004. Occult hepatitis B virus infection: implications in transfusion. Vox Sang. 86:83-91. - PubMed
-
- Allain, J.-P., D. Belkhiri, M. Vermeulen, R. Crookes, R. Cable, A. Amiri, R. Reddy, A. Bird, and D. Candotti. 2009. Characterization of occult hepatitis B virus strains in South African blood donors. Hepatology 49:1868-1876. - PubMed
-
- Allain, J.-P., D. Candotti, K. Soldan, F. Sarkodie, B. Phelps, C. Giachetti, V. Shyamala, F. Yeboah, M. Anokwa, S. Owusu-Ofori, and O. Opare-Sem. 2003. The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana. Blood 101:2419-2425. - PubMed
-
- Behzad-Behbahani, A., A. Mafi-Nejad, S. Z. Tabei, K. B. Lankarani, A. Torab, and A. Moaddeb. 2006. Anti-HBc & HBV DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection. Indian J. Med. Res. 123:37-42. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Medical